Procter & Gamble Company (The) $PG Stock: Sterling Capital Management LLC Lowers Position

Sterling Capital Management LLC cut its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 19.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 27,436 shares of the company’s stock after selling 6,562 shares during the period. Sterling Capital Management LLC’s holdings in Procter & Gamble were worth $3,986,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Kennebec Savings Bank raised its holdings in Procter & Gamble by 3.9% during the third quarter. Kennebec Savings Bank now owns 10,484 shares of the company’s stock valued at $1,523,000 after acquiring an additional 389 shares during the period. TSA Wealth Managment LLC grew its position in shares of Procter & Gamble by 17.8% during the third quarter. TSA Wealth Managment LLC now owns 1,905 shares of the company’s stock worth $277,000 after purchasing an additional 288 shares in the last quarter. BIP Wealth LLC grew its position in shares of Procter & Gamble by 2.3% during the third quarter. BIP Wealth LLC now owns 25,224 shares of the company’s stock worth $3,664,000 after purchasing an additional 569 shares in the last quarter. River Street Advisors LLC grew its position in shares of Procter & Gamble by 32.3% during the third quarter. River Street Advisors LLC now owns 10,955 shares of the company’s stock worth $1,592,000 after purchasing an additional 2,676 shares in the last quarter. Finally, Boomfish Wealth Group LLC raised its stake in Procter & Gamble by 8.3% during the 3rd quarter. Boomfish Wealth Group LLC now owns 15,125 shares of the company’s stock valued at $2,197,000 after purchasing an additional 1,156 shares during the period. Institutional investors own 65.77% of the company’s stock.

Insiders Place Their Bets

In related news, insider Susan Whaley sold 2,369 shares of the stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $344,310.46. Following the sale, the insider owned 30,730 shares in the company, valued at approximately $4,466,298.20. This represents a 7.16% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Matthew W. Janzaruk sold 359 shares of the firm’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the sale, the chief accounting officer owned 1,271 shares of the company’s stock, valued at approximately $184,600.04. This represents a 22.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 15,135 shares of company stock worth $2,189,970. 0.23% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

PG has been the subject of a number of research analyst reports. HSBC reaffirmed a “hold” rating and set a $149.00 price objective (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. BNP Paribas Exane raised their target price on shares of Procter & Gamble from $177.00 to $189.00 and gave the company an “outperform” rating in a research note on Friday. Barclays increased their price objective on shares of Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. TD Cowen raised their price objective on Procter & Gamble from $150.00 to $166.00 and gave the company a “hold” rating in a research report on Friday. Finally, Royal Bank Of Canada set a $169.00 target price on Procter & Gamble in a report on Friday. Fifteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $168.90.

Read Our Latest Analysis on PG

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $161.21 on Friday. The company’s 50-day moving average price is $148.41 and its 200-day moving average price is $147.09. The company has a quick ratio of 0.47, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. The company has a market cap of $374.43 billion, a PE ratio of 24.28, a price-to-earnings-growth ratio of 4.00 and a beta of 0.39. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25.

Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. The firm had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 30.91%. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.99 EPS. On average, equities research analysts forecast that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be paid a $1.0885 dividend. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.71%.

Procter & Gamble News Roundup

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
  • Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
  • Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
  • Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
  • Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook

Procter & Gamble Profile

(Free Report)

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.